names of glp-1 drugs brand GLP-1 Receptor Agonist Shortage: Challenges and Solutions in Type 2 Diabetes Care glp 1 and glp 2
Description
This indicates that there are mechanisms that go well beyond just weight loss or glucose lowering, she says
American journal of physiology Cell physiology
Qazi, S
Wegovy (higher doses, up to 2.4mg) is approved specifically for weight loss
Conversely, the EMP-REG OUTCOME trial found an exciting reduction in CV outcomes in patients with T2DM and known ASCVD that were treated with empagliflozin
doi: 10.1210/endo.139.9.6202
